子宫内膜癌综合性审查:新的分子和FIGO分类以及最近的治疗变化
Maria-Bianca Anca-Stanciu1,2, Andrei Manu1,2, Maria Victoria Olinca1,3
1Department of Gynecology, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania.
Journal of clinical medicine
|February 26, 2025
概括
子宫内膜癌 (EC) 的分类正在随着分子亚型的演变而发展,如POLE超变异和MSI-H,改善了诊断和个性化治疗. 整合这些分子见解可以提高妇科瘤学患者的治疗结果.
科学领域:
- 妇科瘤学 妇科瘤学
- 分子病理学分子病理学
- 癌症基因组学 癌症基因组学
背景情况:
- 子宫内膜癌 (EC) 是主要的妇科恶性瘤,由于人口变化和肥胖,其发病率正在增加.
- 目前的诊断和预后方法正在通过分子见解来改进.
- 个性化治疗策略对于改善患者的治疗结果至关重要.
研究的目的:
- 审查子宫内膜癌分类的演变,重点关注分子和FIGO系统更新.
- 突出分子亚型的诊断,预后和治疗影响.
- 讨论分子诊断的整合和EC管理的未来方向.
主要方法:
- 审查目前关于子宫内膜癌分子和FIGO分类的文献.
- 癌症基因组图谱 (TCGA) 分子亚型 (POLE超变异,MSI-H,CNL,CNH) 的分析.
- 检查最近的FIGO分期系统修订,包括分子特征.
主要成果:
- 分子亚型 (POLE超变异,MSI-H,CNL,CNH) 提供了更精确的EC异质性的理解.
- 对于每个分子亚型,存在不同的遗传,组织学和预后资料.
- 更新的FIGO分期结合了分子数据,用于定制的治疗策略.
结论:
- 分子分类对于准确的EC诊断,预后和个性化治疗至关重要.
- 将分子诊断纳入常规实践是一个关键的未来方向.
- 免疫疗法和向疗法的进步为EC管理提供了新的途径.
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


